[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368250-105":59,"doc-detail-368250-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-value-of-folate-associated-gene-expression-in-stage-ii-colon-cancer","Prognostic value of folate-associated gene expression in stage II colon cancer","","Prognostic variability in stage II colon cancer highlights the need for improved risk stratification. The study evaluates folate-associated gene expression in stage II tumors to clarify tumor biology and support the identification of early prognostic and/or predictive biomarkers. Stage II cases with recurrence are matched to patients with recurrence-free follow-up, and gene expression is assessed for associations with time to recurrence alongside demographic and clinicopathological variables.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-value-of-folate-associated-gene-expression-in-stage-ii-colon-cancer/368250/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-value-of-folate-associated-gene-expression-in-stage-ii-colon-cancer/368250.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main purpose?","Question",{"text":112,"@type":113},"To determine whether folate-associated gene expression in stage II colon cancer can provide insight into tumor biology and help identify early prognostic and/or predictive biomarkers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients selected and how was gene expression measured?",{"text":117,"@type":113},"Patients with stage II colon cancer and recurrence were matched to patients with a 5-year recurrence-free follow-up. Gene expression of multiple folate-associated genes in tumor tissue and matched colon mucosa was analyzed using qPCR.",{"name":119,"@type":110,"acceptedAnswer":120},"Which findings were linked to time to recurrence (TTR)?",{"text":121,"@type":113},"Independent of other covariates, TYMS expression in tumors, pT4 stage, and emergency surgery were associated with TTR, and expression levels differed between tumor and mucosa for all examined genes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368250,1790294974,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of Cancer Research and Clinical Oncology (2025) 151:92  \n[https://doi.org/10.1007/s00432-025-06141-w](https://doi.org/10.1007/s00432-025-06141-w)  \nPrognostic value of folate‑associated gene expression in stage II colon cancer  \nDonia Kaidi1,2 · Elisabeth Odin1 · Yvonne Wettergren1,2 · Elinor Bexe Lindskog1,2  \nReceived: 27 December 2024 / Accepted: 13 February 2025 / Published online: 25 February 2025 © The Author(s) 2025  \nAbstract  \nPurpose Prognostic variability in stage II colon cancer underscores the need for better risk stratification. Analyzing folateassociated gene expression in stage II colon cancer could provide researchers and clinicians with deeper insights into tumor biology and potentially aid in identifying early prognostic and/or predictive biomarkers.  \nMethods Patients with stage II colon cancer and recurrence (n = 48) were matched to patients with a 5 year recurrence-free follow-up (n = 133) . Gene expression of ABCC3, AMT, FPGS, GGH, MFT, PCFT, RFC-1, and TYMS was analyzed in tumor tissue and matching colon mucosa using qPCR and evaluated in relation to time to recurrence (TTR), as well as to demographic and clinicopathological variables.  \nResults Independent of other covariates, TYMS expression in tumors, pT4 stage, and emergency surgery were associated with TTR. There were significant differences in expression levels of all examined genes between tumor and mucosa. ABCC3, GGH, and RFC-1 expression levels differed in mucosa between microsatellite instability-high (MSI-H) compared to microsatellite stable/microsatellite instability-low (MSS/MSI-L) tumors, whereas tumoral expression of AMT, GGH, and TYMS differed between MSI-H and MSS/MSI-L tumors. Depending on tumor location, the expression of ABCC3, AMT, GGH, and RFC-1 in mucosa, as well as the tumoral expression of AMT, GGH, PCFT and RFC-1 differed.  \nConclusion Low tumoral expression of TYMS was associated with worse TTR, independent of MSI status, pT stage, and emergency surgery. The indication of a better outcome for patients with MSI-H status and high tumoral TYMS expression might be of particular interest in the stratification of patients for immunotherapy.  \nKeywords Cancer · Biomarker · Colorectal Neoplams · Prognosis · Folic acid · Thymidylate synthase  \n* Elinor Bexe Lindskog [elinor.bexe-lindskog@surgery.gu.se](elinor.bexe-lindskog@surgery.gu.se)  \nDonia Kaidi  \n[donia.kaidi@gu.se](donia.kaidi@gu.se)  \nElisabeth Odin  \n[elisabeth.odin@dep-surg.gu.se](elisabeth.odin@dep-surg.gu.se)  \nYvonne Wettergren  \n[yvonne.wettergren@dep-surg.gu.se](yvonne.wettergren@dep-surg.gu.se)  \n1 Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden  \n2 Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital, Östra, 416 85 Gothenburg, Sweden  \nIntroduction  \nColorectal cancer is the third most common cancer globally, with an increasing incidence annually, particularly among patients under 50 years of age (Sinicrope 2022) . It is currently one of the leading causes of cancer-related deaths worldwide (Sung et al. 2021) . The disease is classified into stages I–IV, with stage I having the best prognosis and stage IV the worst. In stage II colon cancer, the tumor is confined to the colon without lymph node involvement (Nagtegaalet al. 2020) . Curative treatment involves surgery alone or surgery combined with chemotherapy, which is considered in the presence of high-risk factors. Examples of high-risk features include tumor perforation during surgery, an insufficient number of examined and removed lymph nodes, poorly differentiated tumors, pT4 stage tumors and perineural invasion (Argilés et al. 2020) .  \nMicrosatellite instability (MSI) in tumor DNA, caused by deficient DNA mismatch repair (dMMR), is a well-established positive prognostic factor in stage II colon cancer in terms of relapse-free survival (Argilés et al. 2020) . However, since most colon carcinomas are microsa","cbCaisjOMyTv9XKy","https://ap.wps.com/l/cbCaisjOMyTv9XKy","pdf",1260996,11,"English","# Abstract\n# Introduction\n## Colorectal cancer burden and stage II risk\n## Microsatellite instability and need for additional biomarkers\n## Folate metabolism and folate transporters","[{\"question\":\"What was the study’s main purpose?\",\"answer\":\"To determine whether folate-associated gene expression in stage II colon cancer can provide insight into tumor biology and help identify early prognostic and/or predictive biomarkers.\"},{\"question\":\"How were patients selected and how was gene expression measured?\",\"answer\":\"Patients with stage II colon cancer and recurrence were matched to patients with a 5-year recurrence-free follow-up. Gene expression of multiple folate-associated genes in tumor tissue and matched colon mucosa was analyzed using qPCR.\"},{\"question\":\"Which findings were linked to time to recurrence (TTR)?\",\"answer\":\"Independent of other covariates, TYMS expression in tumors, pT4 stage, and emergency surgery were associated with TTR, and expression levels differed between tumor and mucosa for all examined genes.\"}]","Prognostic value of folate-associated gene expression in stage II colon cancer | PDF",1790175863,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3860c4e79a3e23dafa997247c53b7ace.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/650ad961ac2df66bab6118677fc51501.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e1a1811db909435af0d4245007bf93a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ae2d162fb57c0395074d3bca4776985.webp",980,1301]